World leading cellular immunotherapy research in the news
CoE CIT announces collaboration with Cartherics for the treatment of cutaneous T-cell lymphoma (CTCL)
- Refer to Peter Mac, Cartherics developing a new CAR T-cell therapy | Peter MacCallum Cancer Centre for more information.
CoE CIT announces it is joining forces with America’s Penn Medicine (University of Pennsylvania Health System)
- Refer to Global cancer clinical trial centres partner to accelerate research | Peter MacCallum Cancer Centre for more information.
First commercial CAR-T therapy to be manufactured in Australia at Peter MacCallum Cancer Centre
- Refer to First commercial CAR-T therapy to be manufactured in Australia | Peter MacCallum Cancer Centre for more information.
Milestone as Australia's first T-cell therapy manufacturing license is awarded to Peter Mac based company
- Refer to Milestone as Australia’s first T-Cell therapy manufacturing license is awarded | Peter MacCallum Cancer Centre for more information
The CoE CIT successfully gains funding and is announced
- Refer to Peter Mac Centre of Excellence in Cellular Immunotherapy | Peter MacCallum Cancer Centre for more information
